PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock

February 7, 2024

https://www.globenewswire.com/news-release/2024/02/07/2825084/0/en/PepGen-Announces-Pricing-of-80-1-Million-Underwritten-Offering-of-Common-Stock.html

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the pricing of an underwritten offering of 7,530,000 shares of its common stock at a price to the public of $10.635 per share. The aggregate gross proceeds to PepGen from this offering are expected to be approximately $80.1 million, before deducting underwriting discounts and commissions and offering expenses payable by PepGen. The offering is expected to close on or about February 9, 2024, subject to customary closing conditions.

Read more at globenewswire.com

Related news for (PEPG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.